Management of myelofibrosis during pregnancy: A case report

被引：3

作者：

Zivkovic, Radmila ^{[1
]}

Markovic, Olivera ^{[1
,2
]}

Marisavljevic, Dragomir ^{[1
,2
]}

Terzic, Tatjana ^{[3
]}

Tukic, Ljiljana ^{[4
,5
]}

机构：

[1] Clin Hosp Ctr Bezanijska Kosa, Dept Hematol, Belgrade 11000, Serbia

[2] Univ Belgrade, Fac Med, Belgrade, Serbia

[3] Univ Belgrade, Fac Med, Inst Pathol, Belgrade, Serbia

[4] Mil Med Acad, Clin Hematol, Belgrade 11002, Serbia

[5] Univ Def, Mil Med Acad, Fac Med, Belgrade, Serbia

来源：

VOJNOSANITETSKI PREGLED | 2015年 / 72卷 / 04期

关键词：

myeloproliferative disorders; primary myelofibrosis; pregnancy; interferon-alpha; treatment outcome; ESSENTIAL THROMBOCYTHEMIA;

D O I：

10.2298/VSP1504383Z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction. Primary myelofibrosis (PMF) is a clonal myeloproliferative neoplasm that occurs most commonly in the decade six of life and it is very rare in the young persons. Case report. We reported a 28-year-old female patient with primary myelofibrosis who had a normal pregnancy and delivery in the week 40 of pregnancy without any complications. Two years before the diagnosis of PMF she had normal pregnancy. The patient was treated with interferon-alpha and low dose aspirin during the whole pregnancy and with low-molecular-weight heparin a week before delivery and 6 weeks after. The patient had no complications during pregnancy. She delivered in term with healthy, normal baby weight. Conclusion. Decision about treatment strategy of pregnancy associated hematologic malignancies should be made for each patient individually.

引用

页码：383 / 385

页数：3